<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Anatara Lifesciences Ltd 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=30866></link><description><![CDATA[Anatara Lifesciences Ltd 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 02 May 2026 01:22:03 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2018/05/12_3698601005_20180515130721_7711330584.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Anatara Announces Exclusive Global License Agreement with Zoetis]]></title><link>https://www.newswire.co.kr/newsRead.php?no=869303</link><description><![CDATA[BRISBANE, Australia--(Business Wire/Korea Newswire)--Anatara Lifesciences (ASX:ANR) is delighted to announce an exclusive licensing agreement with Zoetis Inc., the leading global animal health company, for the worldwide development, manufacture, distribution and marketing of Detach® as a non-antibiotic approach to aid in the control of diarrhoeal disease (known as scour) in livestock and in horses...]]></description><pubDate>Tue, 15 May 2018 13:20:00 +0900</pubDate></item><item><title><![CDATA[아나타라, 조에티스와 독점적 글로벌 라이선스 계약 체결]]></title><link>https://www.newswire.co.kr/newsRead.php?no=869304</link><description><![CDATA[브리즈번, 호주--(Business Wire/뉴스와이어)--아나타라 라이프사이언시즈(Anatara Lifesciences)(호주증권거래소:ANR)가 가축과 말의 설사병 제어 보조를 위한 무항생적 접근법인 디태치(Detach®)의 세계적인 개발·제조·유통·마케팅을 위해 선도적 글로벌 동물 의료 기업 조에티스(Zoetis Inc.)와 독점 라이선스 계약을 체결했다고 발표했다.  라이선스 계약 조건에 따라 아나타라는 오스트레일리아를 포함한 전세계에서...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2018/05/3698601005_20180515132804_8974643578.jpg]]></url></image><pubDate>Tue, 15 May 2018 13:20:00 +0900</pubDate></item></channel></rss>